Evidence map›Paper›PMID 21181442›Full record

ArticleDigestive diseases and sciences2011

Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study.

Sean J Pittock, Vanda A Lennon, Carissa L Dege, Nicholas J Talley, G Richard Locke

Open access · greenAbstract read
In one paragraph

Article in Digestive diseases and sciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Gastrointestinal motility disorders in neurologic disease.The Journal of clinical investigation · 2021
    Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Sean J PittockDivision of Multiple Sclerosis and Autoimmune Neurology, Department of Neurology, Mayo Clinic, 200 First Street S.W., Rochester, MN 55905, USA. pittock.sean@mayo.edu
Vanda A Lennon
Carissa L Dege
Nicholas J Talley
G Richard Locke
Mayo Clinic · USMayo Clinic in Arizona · USMayo Clinic in Florida · US

Funding

ZESTRIL VS. VERAPAMIL IN THE TREATMENT OF HYPERTENSIONM01RR000585 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 1985 to 2006
$30.4M
Physiological Characterization and Data Integration CoreP01DK068055 · NIDDK · MAYO CLINIC ROCHESTER · PI ORDOG, TAMAS · 2004 to 2019
$23.8M
Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
ROCHESTER EPIDEMIOLOGY PROJECTR01AR030582 · NIAMS · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A · 1986 to 2009
$5.1M
EPIDEMIOLOGY OF CELIAC DISEASE--A POPULATION BASED STUDYR01DK057892 · NIDDK · MAYO CLINIC ROCHESTER · PI MURRAY, JOSEPH A · 2000 to 2010
$3.9M
Spectrum of Autoimmune Gastrointestinal DysmotilityR01DK071209 · NIDDK · MAYO CLINIC ROCHESTER · PI LENNON, VANDA A · 2005 to 2009
$1.6M
NCRR NIH HHS M01 RR000585NCRR NIH HHS M01RR585NIAMS NIH HHS AR30582NIAMS NIH HHS R01 AR030582NIA NIH HHS R01 AG034676NIDDK NIH HHS DK68055NIDDK NIH HHS DK71209NIDDK NIH HHS P01 DK068055NIDDK NIH HHS R01 DK057892NIDDK NIH HHS R01 DK071209
6 · The paper itself

Abstract

backgroundOur goal is to investigate the serum profile of neural autoantibodies in community-based patients with irritable bowel syndrome (IBS) or functional dyspepsia. The pathogenesis of functional gastrointestinal (GI) disorders, including IBS and dyspepsia, are unknown. Theories range from purely psychological to autoimmune alterations in GI tract neuromuscular function.

methodsThe study subjects, based in Olmsted County, MN, reported symptoms of functional dyspepsia or IBS (n = 69), or were asymptomatic controls (n = 64). Their coded sera were screened for antibodies targeting neuronal, glial, and muscle autoantigens.

resultsThe prevalence of neural autoantibodies with functional GI disorders did not differ significantly from controls (17% vs. 13%; P = 0.43). In no case was a neuronal or glial nuclear autoantibody or enteric neuronal autoantibody identified. Neuronal cation channel antibodies were identified in 9% of cases (voltage-gated potassium channel [VGKC] in one dyspepsia case and one IBS case, ganglionic acetylcholine receptor [AChR] in four IBS cases) and in 6% of controls (ganglionic AChR in one, voltage-gated calcium channel [VGCC], N-type, in two and VGKC in one; P = 0.36). The frequency of glutamic acid decarboxylase-65 (GAD65) autoantibodies was similar in cases (10%) and controls (5%; P = 0.23).

conclusionsOur data do not support neural autoimmunity as the basis for most IBS or functional dyspepsia cases.

Indexed as

AdultAutoantibodiesCase-Control StudiesDyspepsiaFemaleHumansIrritable Bowel SyndromeMaleMuscle, SkeletalNeurogliaNeuronsAutoantibodies

Identifiers

PMID21181442
PMCPMC3089890
OpenAlexW2079105897

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.